 | • レポートコード：MRC2-11QY10447 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はT細胞特異的表面糖タンパク質CD28のグローバル市場について調査・分析したレポートです。種類別（FPT-155、FR-104、ルリズマブペゴル、その他）市場規模、用途別（尋常性乾癬、固形腫瘍、急性腎不全（ARF）、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別T細胞特異的表面糖タンパク質CD28の競争状況、市場シェア ・世界のT細胞特異的表面糖タンパク質CD28市場：種類別市場規模 2015年-2020年（FPT-155、FR-104、ルリズマブペゴル、その他） ・世界のT細胞特異的表面糖タンパク質CD28市場：種類別市場規模予測 2021年-2026年（FPT-155、FR-104、ルリズマブペゴル、その他） ・世界のT細胞特異的表面糖タンパク質CD28市場：用途別市場規模 2015年-2020年（尋常性乾癬、固形腫瘍、急性腎不全（ARF）、その他） ・世界のT細胞特異的表面糖タンパク質CD28市場：用途別市場規模予測 2021年-2026年（尋常性乾癬、固形腫瘍、急性腎不全（ARF）、その他） ・北米のT細胞特異的表面糖タンパク質CD28市場分析：米国、カナダ ・ヨーロッパのT細胞特異的表面糖タンパク質CD28市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのT細胞特異的表面糖タンパク質CD28市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のT細胞特異的表面糖タンパク質CD28市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのT細胞特異的表面糖タンパク質CD28市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Atox Bio Ltd、Bristol-Myers Squibb Co、Five Prime Therapeutics Inc、Johnson & Johnson、TheraMAB LLC ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global T Cell Specific Surface Glycoprotein CD28 Market
The global T Cell Specific Surface Glycoprotein CD28 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global T Cell Specific Surface Glycoprotein CD28 Scope and Market Size
T Cell Specific Surface Glycoprotein CD28 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global T Cell Specific Surface Glycoprotein CD28 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the T Cell Specific Surface Glycoprotein CD28 market is segmented into
FPT-155
FR-104
Lulizumab Pegol
Others
Segment by Application, the T Cell Specific Surface Glycoprotein CD28 market is segmented into
Plaque Psoriasis
Solid Tumor
Acute Renal Failure(ARF)
Others
Regional and Country-level Analysis
The T Cell Specific Surface Glycoprotein CD28 market is analysed and market size information is provided by regions (countries).
The key regions covered in the T Cell Specific Surface Glycoprotein CD28 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and T Cell Specific Surface Glycoprotein CD28 Market Share Analysis
T Cell Specific Surface Glycoprotein CD28 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in T Cell Specific Surface Glycoprotein CD28 business, the date to enter into the T Cell Specific Surface Glycoprotein CD28 market, T Cell Specific Surface Glycoprotein CD28 product introduction, recent developments, etc.
The major vendors covered:
Atox Bio Ltd
Bristol-Myers Squibb Co
Five Prime Therapeutics Inc
Johnson & Johnson
TheraMAB LLC
…
1 Study Coverage
1.1 T Cell Specific Surface Glycoprotein CD28 Product Introduction
1.2 Market Segments
1.3 Key T Cell Specific Surface Glycoprotein CD28 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate by Type
1.4.2 FPT-155
1.4.3 FR-104
1.4.4 Lulizumab Pegol
1.4.5 Others
1.5 Market by Application
1.5.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate by Application
1.5.2 Plaque Psoriasis
1.5.3 Solid Tumor
1.5.4 Acute Renal Failure(ARF)
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size, Estimates and Forecasts
2.1.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue 2015-2026
2.1.2 Global T Cell Specific Surface Glycoprotein CD28 Sales 2015-2026
2.2 Global T Cell Specific Surface Glycoprotein CD28, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global T Cell Specific Surface Glycoprotein CD28 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global T Cell Specific Surface Glycoprotein CD28 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global T Cell Specific Surface Glycoprotein CD28 Competitor Landscape by Players
3.1 T Cell Specific Surface Glycoprotein CD28 Sales by Manufacturers
3.1.1 T Cell Specific Surface Glycoprotein CD28 Sales by Manufacturers (2015-2020)
3.1.2 T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Manufacturers (2015-2020)
3.2 T Cell Specific Surface Glycoprotein CD28 Revenue by Manufacturers
3.2.1 T Cell Specific Surface Glycoprotein CD28 Revenue by Manufacturers (2015-2020)
3.2.2 T Cell Specific Surface Glycoprotein CD28 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global T Cell Specific Surface Glycoprotein CD28 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by T Cell Specific Surface Glycoprotein CD28 Revenue in 2019
3.2.5 Global T Cell Specific Surface Glycoprotein CD28 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 T Cell Specific Surface Glycoprotein CD28 Price by Manufacturers
3.4 T Cell Specific Surface Glycoprotein CD28 Manufacturing Base Distribution, Product Types
3.4.1 T Cell Specific Surface Glycoprotein CD28 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers T Cell Specific Surface Glycoprotein CD28 Product Type
3.4.3 Date of International Manufacturers Enter into T Cell Specific Surface Glycoprotein CD28 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size by Type (2015-2020)
4.1.1 Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2015-2020)
4.1.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2015-2020)
4.1.3 T Cell Specific Surface Glycoprotein CD28 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Type (2021-2026)
4.2.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Type (2021-2026)
4.2.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Type (2021-2026)
4.2.3 T Cell Specific Surface Glycoprotein CD28 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global T Cell Specific Surface Glycoprotein CD28 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size by Application (2015-2020)
5.1.1 Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2015-2020)
5.1.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2015-2020)
5.1.3 T Cell Specific Surface Glycoprotein CD28 Price by Application (2015-2020)
5.2 T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Application (2021-2026)
5.2.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Application (2021-2026)
5.2.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Application (2021-2026)
5.2.3 Global T Cell Specific Surface Glycoprotein CD28 Price Forecast by Application (2021-2026)
6 North America
6.1 North America T Cell Specific Surface Glycoprotein CD28 by Country
6.1.1 North America T Cell Specific Surface Glycoprotein CD28 Sales by Country
6.1.2 North America T Cell Specific Surface Glycoprotein CD28 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America T Cell Specific Surface Glycoprotein CD28 Market Facts & Figures by Type
6.3 North America T Cell Specific Surface Glycoprotein CD28 Market Facts & Figures by Application
7 Europe
7.1 Europe T Cell Specific Surface Glycoprotein CD28 by Country
7.1.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country
7.1.2 Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe T Cell Specific Surface Glycoprotein CD28 Market Facts & Figures by Type
7.3 Europe T Cell Specific Surface Glycoprotein CD28 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific T Cell Specific Surface Glycoprotein CD28 by Region
8.1.1 Asia Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Region
8.1.2 Asia Pacific T Cell Specific Surface Glycoprotein CD28 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific T Cell Specific Surface Glycoprotein CD28 Market Facts & Figures by Type
8.3 Asia Pacific T Cell Specific Surface Glycoprotein CD28 Market Facts & Figures by Application
9 Latin America
9.1 Latin America T Cell Specific Surface Glycoprotein CD28 by Country
9.1.1 Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Country
9.1.2 Latin America T Cell Specific Surface Glycoprotein CD28 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America T Cell Specific Surface Glycoprotein CD28 Market Facts & Figures by Type
9.3 Central & South America T Cell Specific Surface Glycoprotein CD28 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 by Country
10.1.1 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country
10.1.2 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Facts & Figures by Type
10.3 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Facts & Figures by Application
11 Company Profiles
11.1 Atox Bio Ltd
11.1.1 Atox Bio Ltd Corporation Information
11.1.2 Atox Bio Ltd Description and Business Overview
11.1.3 Atox Bio Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Products Offered
11.1.5 Atox Bio Ltd Related Developments
11.2 Bristol-Myers Squibb Co
11.2.1 Bristol-Myers Squibb Co Corporation Information
11.2.2 Bristol-Myers Squibb Co Description and Business Overview
11.2.3 Bristol-Myers Squibb Co Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Products Offered
11.2.5 Bristol-Myers Squibb Co Related Developments
11.3 Five Prime Therapeutics Inc
11.3.1 Five Prime Therapeutics Inc Corporation Information
11.3.2 Five Prime Therapeutics Inc Description and Business Overview
11.3.3 Five Prime Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Products Offered
11.3.5 Five Prime Therapeutics Inc Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 TheraMAB LLC
11.5.1 TheraMAB LLC Corporation Information
11.5.2 TheraMAB LLC Description and Business Overview
11.5.3 TheraMAB LLC Sales, Revenue and Gross Margin (2015-2020)
11.5.4 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Products Offered
11.5.5 TheraMAB LLC Related Developments
11.1 Atox Bio Ltd
11.1.1 Atox Bio Ltd Corporation Information
11.1.2 Atox Bio Ltd Description and Business Overview
11.1.3 Atox Bio Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Products Offered
11.1.5 Atox Bio Ltd Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 T Cell Specific Surface Glycoprotein CD28 Market Estimates and Projections by Region
12.1.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Regions 2021-2026
12.1.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Regions 2021-2026
12.2 North America T Cell Specific Surface Glycoprotein CD28 Market Size Forecast (2021-2026)
12.2.1 North America: T Cell Specific Surface Glycoprotein CD28 Sales Forecast (2021-2026)
12.2.2 North America: T Cell Specific Surface Glycoprotein CD28 Revenue Forecast (2021-2026)
12.2.3 North America: T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Country (2021-2026)
12.3 Europe T Cell Specific Surface Glycoprotein CD28 Market Size Forecast (2021-2026)
12.3.1 Europe: T Cell Specific Surface Glycoprotein CD28 Sales Forecast (2021-2026)
12.3.2 Europe: T Cell Specific Surface Glycoprotein CD28 Revenue Forecast (2021-2026)
12.3.3 Europe: T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific T Cell Specific Surface Glycoprotein CD28 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: T Cell Specific Surface Glycoprotein CD28 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: T Cell Specific Surface Glycoprotein CD28 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Region (2021-2026)
12.5 Latin America T Cell Specific Surface Glycoprotein CD28 Market Size Forecast (2021-2026)
12.5.1 Latin America: T Cell Specific Surface Glycoprotein CD28 Sales Forecast (2021-2026)
12.5.2 Latin America: T Cell Specific Surface Glycoprotein CD28 Revenue Forecast (2021-2026)
12.5.3 Latin America: T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: T Cell Specific Surface Glycoprotein CD28 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: T Cell Specific Surface Glycoprotein CD28 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key T Cell Specific Surface Glycoprotein CD28 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 T Cell Specific Surface Glycoprotein CD28 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. T Cell Specific Surface Glycoprotein CD28 Market Segments
Table 2. Ranking of Global Top T Cell Specific Surface Glycoprotein CD28 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of FPT-155
Table 5. Major Manufacturers of FR-104
Table 6. Major Manufacturers of Lulizumab Pegol
Table 7. Major Manufacturers of Others
Table 8. Global T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global T Cell Specific Surface Glycoprotein CD28 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global T Cell Specific Surface Glycoprotein CD28 Sales by Regions 2015-2020 (K Pcs)
Table 11. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Regions (2015-2020)
Table 12. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global T Cell Specific Surface Glycoprotein CD28 Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global T Cell Specific Surface Glycoprotein CD28 Sales Share by Manufacturers (2015-2020)
Table 15. Global T Cell Specific Surface Glycoprotein CD28 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global T Cell Specific Surface Glycoprotein CD28 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T Cell Specific Surface Glycoprotein CD28 as of 2019)
Table 17. T Cell Specific Surface Glycoprotein CD28 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. T Cell Specific Surface Glycoprotein CD28 Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers T Cell Specific Surface Glycoprotein CD28 Price (2015-2020) (USD/Pcs)
Table 20. T Cell Specific Surface Glycoprotein CD28 Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers T Cell Specific Surface Glycoprotein CD28 Product Type
Table 22. Date of International Manufacturers Enter into T Cell Specific Surface Glycoprotein CD28 Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2015-2020) (K Pcs)
Table 25. Global T Cell Specific Surface Glycoprotein CD28 Sales Share by Type (2015-2020)
Table 26. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2015-2020) (US$ Million)
Table 27. Global T Cell Specific Surface Glycoprotein CD28 Revenue Share by Type (2015-2020)
Table 28. T Cell Specific Surface Glycoprotein CD28 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2015-2020) (K Pcs)
Table 30. Global T Cell Specific Surface Glycoprotein CD28 Sales Share by Application (2015-2020)
Table 31. North America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2015-2020) (K Pcs)
Table 32. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2015-2020)
Table 33. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2015-2020) (US$ Million)
Table 34. North America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country (2015-2020)
Table 35. North America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2015-2020) (K Pcs)
Table 36. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2015-2020)
Table 37. North America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2015-2020) (K Pcs)
Table 38. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2015-2020)
Table 39. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2015-2020) (K Pcs)
Table 40. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2015-2020)
Table 41. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country (2015-2020)
Table 43. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Type (2015-2020) (K Pcs)
Table 44. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2015-2020)
Table 45. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application (2015-2020) (K Pcs)
Table 46. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2015-2020)
Table 55. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country (2015-2020)
Table 59. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2015-2020)
Table 61. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2015-2020)
Table 71. Atox Bio Ltd Corporation Information
Table 72. Atox Bio Ltd Description and Major Businesses
Table 73. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Atox Bio Ltd Product
Table 75. Atox Bio Ltd Recent Development
Table 76. Bristol-Myers Squibb Co Corporation Information
Table 77. Bristol-Myers Squibb Co Description and Major Businesses
Table 78. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Bristol-Myers Squibb Co Product
Table 80. Bristol-Myers Squibb Co Recent Development
Table 81. Five Prime Therapeutics Inc Corporation Information
Table 82. Five Prime Therapeutics Inc Description and Major Businesses
Table 83. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Five Prime Therapeutics Inc Product
Table 85. Five Prime Therapeutics Inc Recent Development
Table 86. Johnson & Johnson Corporation Information
Table 87. Johnson & Johnson Description and Major Businesses
Table 88. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Johnson & Johnson Product
Table 90. Johnson & Johnson Recent Development
Table 91. TheraMAB LLC Corporation Information
Table 92. TheraMAB LLC Description and Major Businesses
Table 93. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. TheraMAB LLC Product
Table 95. TheraMAB LLC Recent Development
Table 96. Global T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 97. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share Forecast by Regions (2021-2026)
Table 98. Global T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 99. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share Forecast by Regions (2021-2026)
Table 100. North America: T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2021-2026) (K Pcs)
Table 101. North America: T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Europe: T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Europe: T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Asia Pacific: T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Region (2021-2026) (K Pcs)
Table 105. Asia Pacific: T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 106. Latin America: T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. Latin America: T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Middle East and Africa: T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Middle East and Africa: T Cell Specific Surface Glycoprotein CD28 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 111. Key Challenges
Table 112. Market Risks
Table 113. Main Points Interviewed from Key T Cell Specific Surface Glycoprotein CD28 Players
Table 114. T Cell Specific Surface Glycoprotein CD28 Customers List
Table 115. T Cell Specific Surface Glycoprotein CD28 Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. T Cell Specific Surface Glycoprotein CD28 Product Picture
Figure 2. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type in 2020 & 2026
Figure 3. FPT-155 Product Picture
Figure 4. FR-104 Product Picture
Figure 5. Lulizumab Pegol Product Picture
Figure 6. Others Product Picture
Figure 7. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application in 2020 & 2026
Figure 8. Plaque Psoriasis
Figure 9. Solid Tumor
Figure 10. Acute Renal Failure(ARF)
Figure 11. Others
Figure 12. T Cell Specific Surface Glycoprotein CD28 Report Years Considered
Figure 13. Global T Cell Specific Surface Glycoprotein CD28 Market Size 2015-2026 (US$ Million)
Figure 14. Global T Cell Specific Surface Glycoprotein CD28 Sales 2015-2026 (K Pcs)
Figure 15. Global T Cell Specific Surface Glycoprotein CD28 Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region (2015-2020)
Figure 17. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region in 2019
Figure 18. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region (2015-2020)
Figure 19. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region in 2019
Figure 20. Global T Cell Specific Surface Glycoprotein CD28 Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by T Cell Specific Surface Glycoprotein CD28 Revenue in 2019
Figure 22. T Cell Specific Surface Glycoprotein CD28 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2015-2020)
Figure 24. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type in 2019
Figure 25. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2015-2020)
Figure 26. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type in 2019
Figure 27. Global T Cell Specific Surface Glycoprotein CD28 Market Share by Price Range (2015-2020)
Figure 28. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2015-2020)
Figure 29. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application in 2019
Figure 30. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2015-2020)
Figure 31. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application in 2019
Figure 32. North America T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country in 2019
Figure 35. North America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country in 2019
Figure 36. U.S. T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America T Cell Specific Surface Glycoprotein CD28 Market Share by Type in 2019
Figure 41. North America T Cell Specific Surface Glycoprotein CD28 Market Share by Application in 2019
Figure 42. Europe T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country in 2019
Figure 45. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country in 2019
Figure 46. Germany T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe T Cell Specific Surface Glycoprotein CD28 Market Share by Type in 2019
Figure 57. Europe T Cell Specific Surface Glycoprotein CD28 Market Share by Application in 2019
Figure 58. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region in 2019
Figure 61. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region in 2019
Figure 62. China T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Market Share by Type in 2019
Figure 85. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Market Share by Application in 2019
Figure 86. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country in 2019
Figure 89. Latin America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country in 2019
Figure 90. Mexico T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America T Cell Specific Surface Glycoprotein CD28 Market Share by Type in 2019
Figure 97. Latin America T Cell Specific Surface Glycoprotein CD28 Market Share by Application in 2019
Figure 98. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country in 2019
Figure 101. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country in 2019
Figure 102. Turkey T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Share by Type in 2019
Figure 109. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Share by Application in 2019
Figure 110. North America T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
T細胞表面糖タンパク質CD4の世界市場（～2026年） Market Analysis and Insights: Global T Cell Surface Glycoprotein CD4 Market The global T Cell Surface Glycoprotein CD4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global T Cell Surface Glycoprotein CD4 Scope and Market Si…- T細胞表面糖タンパク質CD3イプシロン鎖の世界市場（～2026年） Market Analysis and Insights: Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market The global T Cell Surface Glycoprotein CD3 Epsilon Chain market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global T Cell Surface Glycopro…
- 細胞表面マーカー検出の世界市場（～2026年） Cell surface markers are also known as cell surface antigen serves as monograms to help identify and classify cells. There is an increase in demand for the cell surface marker detection market owing to the advancements in high-throughput tools and techniques used for cytological analysis. Market Ana…
- 細胞培養タンパク質表面コーティングの世界市場（～2026年） Cell culture is a complex procedure in which cells are grown under controlled physical conditions outside the natural environment. These cells are used to develop model systems for research, study of cellular structure and functions, stem cell research, drug discovery and genetic engineering. Growin…
- 呼吸器合胞体ウイルス付着糖タンパク質の世界市場（～2026年） Market Analysis and Insights: Global Respiratory Syncytial Virus Attachment Glycoprotein Market The global Respiratory Syncytial Virus Attachment Glycoprotein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Respiratory…